Prävention von Taschenkomplikationen nach Implantation von Herzrhythmusdevices
Herzschrittmachertherapie + Elektrophysiologie · 2015-03 · 26 (1) · 45-51
DOI: 10.1007/s00399-015-0349-7 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Herzschrittmachertherapie + Elektrophysiologie, online erschienen am 03.02.2015. Verfasst von Marc-Alexander Ohlow und 5 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Kardiologie, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99437, Bad Berka, Deutschland, marc.ohlow@zentralklinik.de. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Pocket hematoma is a common complication after heart rhythm device implantation (HRD) in patients receiving anticoagulation and/or dual antiplatelet therapy (DAPT). METHODS: We conducted a prospective case-control study and enrolled all patients admitted for HRD receiving anticoagulation or DAPT. Participants received D-Stat (a mixture of collagen and thrombin) into the pectoral pocket and were compared with an age- and gender-matched group receiving a vacuum drainage system. The primary endpoint was a composite of hematoma needing evacuation and pocket infection. RESULTS: We included a total of 164 patients (mean age 73 ± 10.7 years; 118 [72 %] men). In all, 82 patients (50 %) received D-stat and 82 (50 %) vacuum drainage. There were 83 (51 %) patients who were treated with anticoagulation, 69 (42 %) patients received DAPT, and 11 (7 %) patients both. The primary endpoint occurred in 14.5 % (12/82) of patients in the D-Stat group and 0 % (0/82) of patients in the drainage group (p < 0.01). The use of D-Stat solution was associated with an increased incidence of pocket hematoma requiring evacuation (8.5 % versus 0 %; p = 0.01), and tended to an increased rate of pocket infections (6.1 % versus 0 %; p = 0.06). Postoperative immunoglobulin E levels (106 ± 219 IU/ml [D-Stat] versus 117 ± 189 IU/ml [drainage]) and increase of C-reactive protein (D-Stat: ∆19 mg/l versus drainage: ∆21 mg/l) were similar in both groups (p = 0.7 and p = 0.5, respectively). CONCLUSIONS: Administration of D-Stat solution is associated with a higher rate of pocket hematoma requiring reoperation in a high risk population receiving anticoagulation and/or DAPT. The observed rate of pocket infections in the D-Stat group is a matter of concern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Klinik für Kardiologie, Zentralklinik Bad Berka, Robert-Koch-Allee 9, 99437, Bad Berka, Deutschland, marc.ohlow@zentralklinik.de.
Zitieren
APA
Ohlow, M. A., Buchter, B., Brunelli, M., Lauer, B., Schreiber, M., & Geller, J. C. (2015). Prävention von Taschenkomplikationen nach Implantation von Herzrhythmusdevices. Herzschrittmachertherapie + Elektrophysiologie, 26(1), 45-51. https://doi.org/10.1007/s00399-015-0349-7
Vancouver
Ohlow MA, Buchter B, Brunelli M, Lauer B, Schreiber M, Geller JC. Prävention von Taschenkomplikationen nach Implantation von Herzrhythmusdevices. Herzschrittmachertherapie + Elektrophysiologie. 2015;26(1):45-51. doi:10.1007/s00399-015-0349-7
BibTeX
@article{Ohlow2015,
author = {Ohlow, Marc-Alexander and Buchter, Björn and Brunelli, Michele and Lauer, Bernward and Schreiber, Matthias and Geller, J Christoph},
title = {Prävention von Taschenkomplikationen nach Implantation von Herzrhythmusdevices},
journal = {Herzschrittmachertherapie + Elektrophysiologie},
year = {2015},
volume = {26},
number = {1},
pages = {45--51},
doi = {10.1007/s00399-015-0349-7}
}
EUVIMED